ACTIVE

ARSPHARMA

Export PDF
Financial year 2025 · closed on 30/09/2025
Net result
28,1 k €
+125.4% YoY
Gross margin
101,9 k €
+45.6% YoY
Equity
197,9 k €
+16.6% YoY
Workforce
0,5 ETP
0.0% YoY

What does ARSPHARMA do?

ARSPHARMA is a Private limited company incorporated in 2012. Its main activity is: Architectural activities. Its registered office is in Malle. It employs on average 0,5 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0849.745.437
Incorporation
12/10/2012
Legal form
Private limited company
Registered office
Antwerpsesteenweg 281A
2390 Malle · FlandreSee on map
Contributed capital
6 300,00 €
Latest accounts
30/09/2025
Average workforce
0,5 ETP
Activities (NACE)
71112Architectural activities· main71112Architectural activities70200Management consultancy activities70220Business and other management consultancy activities
Joint committees (2)
  • 200
  • 218
Signals
ProfitablePositive cashflowPositive EBITDAHealthy social debts
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 13 financial years

2025202420232022202120202019201820172016201520142013
Income statement
Gross margin101,9 k €69,9 k €92,4 k €40,5 k €60,4 k €70,4 k €104,8 k €-24,3 k €66,3 k €70,6 k €33,2 k €13,2 k €34,8 k €
EBITDA76,2 k €35,2 k €63,5 k €18,5 k €37,7 k €56,5 k €103,3 k €-25,9 k €64,1 k €70,3 k €32,6 k €12,7 k €33,8 k €
Operating result65 k €25,1 k €53,7 k €8,8 k €27,9 k €46,8 k €93,5 k €-42,9 k €47,1 k €53,3 k €31,6 k €11,2 k €31,8 k €
Net result28,1 k €12,5 k €32,3 k €-1,1 k €14 k €26,3 k €75,3 k €-44,7 k €29,7 k €32 k €23,8 k €7,3 k €20,9 k €
Balance sheet
Equity197,9 k €169,7 k €157,3 k €125 k €126,1 k €112,1 k €85,8 k €10,4 k €55,1 k €90,4 k €58,4 k €34,6 k €27,2 k €
Total assets839,1 k €703,9 k €847,7 k €775,3 k €872 k €1 M €529,6 k €446,1 k €439,7 k €599,9 k €643,1 k €321,3 k €157,5 k €
Cash108,5 k €119 k €187,7 k €153,4 k €288,2 k €315,6 k €268,5 k €92 k €157,7 k €355,5 k €512,2 k €269,1 k €127,7 k €
Debts631,3 k €534,1 k €576 k €531,7 k €714,9 k €678 k €307,9 k €333,2 k €318,6 k €362,3 k €134,9 k €119,3 k €37,2 k €
Other
Workforce0,5 ETP0,5 ETP0,5 ETP0,5 ETP0,5 ETP0,3 ETP–––––––
Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation
Governance

Board of directors

Seen on filing of 30/09/2025 · 1 active · 8 ended

Active mandates

REMEDIA

Mandate · 0808.150.154

Represented by Firmin Boonen

Active

Ended mandates

REMEDIA

Director · since 20 février 2020 · 0808.150.154

Represented by Firmin Boonen

Ended
REMEDIA

Director · since 20 février 2020 · 0808.150.154

Represented by Firmin Boonen

Ended
GLOBAL PHARMA GROUP

Manager · since 12 octobre 2012 · 0849.471.758

Represented by FIRMIN BOONEN

Ended
GLOBAL PHARMA GROUP

Manager · since 12 octobre 2012 · until 01 mars 2016 · 0849.471.758

Represented by Firmin Boonen

Ended
Annual accounts

Full financial information

202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/10/202401/10/202301/10/202201/10/202101/10/202001/10/2019
Closing of the financial year30/09/202530/09/202430/09/202330/09/202230/09/202130/09/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date29/04/202630/04/202502/05/202428/04/202329/04/202229/01/2021
General meeting03/02/202620/12/202420/12/202320/12/202220/12/202120/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

13 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/09/202503/02/202629/04/2026DutchPDF
Abridged model30/09/202420/12/202430/04/2025DutchPDF
Abridged model30/09/202320/12/202302/05/2024DutchPDF
Abridged model30/09/202220/12/202228/04/2023DutchPDF
Abridged model30/09/202120/12/202129/04/2022DutchPDF
Abridged model30/09/202020/12/202029/01/2021DutchPDF
Abridged model30/09/201920/12/201931/01/2020DutchPDF
Abridged model30/09/201820/12/201831/01/2019DutchPDF
Abridged model30/09/201720/12/201731/01/2018DutchPDF
Abridged model30/09/201620/12/201631/01/2017DutchPDF
Abridged model30/09/201520/12/201501/02/2016DutchPDF
Abridged model30/09/201410/01/201510/02/2015DutchPDF
Abridged model30/09/201310/01/201431/03/2014DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/09/2025 · 1 active · 8 ended

Active mandates

REMEDIA

Mandate · 0808.150.154

Represented by Firmin Boonen

Active

Ended mandates

REMEDIA

Director · since 20 février 2020 · 0808.150.154

Represented by Firmin Boonen

Ended
REMEDIA

Director · since 20 février 2020 · 0808.150.154

Represented by Firmin Boonen

Ended
GLOBAL PHARMA GROUP

Manager · since 12 octobre 2012 · 0849.471.758

Represented by FIRMIN BOONEN

Ended
GLOBAL PHARMA GROUP

Manager · since 12 octobre 2012 · until 01 mars 2016 · 0849.471.758

Represented by Firmin Boonen

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Restructuring11/10/2021
    RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF
  • Mandates24/02/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/06/2016
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other30/10/2012
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 202528,1 k €↑
  2. 2024
    Annual accounts 202412,5 k €↓
  3. 2023
    Annual accounts 202332,3 k €↑
  4. 2022
    Annual accounts 2022-1,1 k €↓
  5. 2021
    Annual accounts 202114 k €↓
  6. 2020
    Annual accounts 202026,3 k €↓
  7. 2019
    Annual accounts 201975,3 k €↑
  8. 2018
    Annual accounts 2018-44,7 k €↓
  9. 2017
    Annual accounts 201729,7 k €↓
  10. 2016
    Annual accounts 201632 k €↑
  11. 2015
    Annual accounts 201523,8 k €↑
  12. 2014
    Annual accounts 20147,3 k €↓
  13. 2013
    Annual accounts 201320,9 k €
  14. 12/10/2012
    IncorporationPrivate limited company